Marc R. Bloomenstein, OD, FAAO
Show Description +
A plethora of new products hit the eye care market in 2021, and Marc R. Bloomenstein, OD, FAAO, looks back at the ripples they made throughout optometric practices. Dr. Bloomenstein reviews the new FDA-approved treatments, contact lenses, biosimilars, and mechanisms of action that he’s used in the past year before looking ahead to the advancements he’s anticipating in 2022.
Posted: 1/27/2022
Marc R. Bloomenstein, OD, FAAO
A plethora of new products hit the eye care market in 2021, and Marc R. Bloomenstein, OD, FAAO, looks back at the ripples they made throughout optometric practices. Dr. Bloomenstein reviews the new FDA-approved treatments, contact lenses, biosimilars, and mechanisms of action that he’s used in the past year before looking ahead to the advancements he’s anticipating in 2022.
Posted: 1/27/2022
Please log in to leave a comment.